Therapy Areas: Oncology
Sidekick Health collaborates with Eli Lilly and Company
20 June 2022 -

Sidekick Health, an Iceland-based international digital therapeutics (DTx) innovator, announced on Friday that it has collaborated with United States-based Eli Lilly and Company, for an integrated digital therapeutics solution intended to treat breast cancer.

The integrated digital therapeutics offering will initially be rolled out in Germany. This further expansion of Sidekick's portfolio to treat breast cancer will be tailored to support the needs of patients within Lilly's oncology treatment programs.

The launch of this digital solution for breast cancer patients in Germany, as well as patients on a branded Lilly medication, is being scheduled for July of this year. Next steps for collaboration are being considered, including other international markets.